tiprankstipranks
Trending News
More News >
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Ownership - Who Owns Xilio Therapeutics?

Compare
160 Followers

Xilio Therapeutics (XLO) Ownership Overview

17.59%2.47%1.29%1.86%76.79%
17.59% Insiders
1.29% Other Institutional Investors
1.86% ETFs
76.79% Public Companies and
Individual Investors
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 5.62% of the company’s stock is owned by Institutional Investors, 17.59% is owned by Insiders, and 76.79% is owned by Public Companies and Individual Investors.
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 3.75% of the company’s stock is owned by Institutional Investors, 17.59% is owned by Insiders, and 1.86% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 19, 2024
xxxxxxxxxxxxx
$1830377

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,105,451Insider17.59%6,483,081
899,587Institution1.74%640,506
899,587Institution1.74%640,506
304,560Institution0.59%216,847
71,081Institution0.14%50,610
65,074Institution0.13%46,333
1,107Institution<0.01%788

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
899,587Institution1.74%640,506
304,560Institution0.59%216,847
71,081Institution0.14%50,610
1,107Institution<0.01%788

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
739,563Institution1.43%670,044
160,024Institution0.31%144,982
64,612Institution0.12%46,004

FAQ

Who Owns Xilio Therapeutics (XLO)?
According to the latest TipRanks data, approximately 1.29% of the company's stock is held by institutional investors, 17.59% is held by insiders, and 76.79% is held by retail investors.
    What percentage of Xilio Therapeutics (XLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.29% of Xilio Therapeutics (XLO) stock is held by institutional investors.
      What percentage of Xilio Therapeutics (XLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 76.79% of Xilio Therapeutics (XLO) stock is held by retail investors.
        Who owns the most shares of Xilio Therapeutics (XLO)?
        Gilead Sciences Inc owns the most shares of Xilio Therapeutics (XLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis